Talk:Catumaxomab

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Catumaxomab.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

T-lymphocytes

Catumaxomab works by linking the T-lymphocytes with the cancer cells. --Blake3522 08:24, 14 July 2007 (UTC)[reply]

Yes. --Blake3522 10:33, 27 July 2007 (UTC)[reply]

No mention of Bispecific

Just thought I'd leave a note to say there's no mention of bispecific on this page and its somewhat significant as being the first approved (see bispecific wiki page and also https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784585/). If anyone wants to add it, that'd be great, I'll add it at some point in the future if not (bit busy currently). --TobyBrann 16:02, 13 August 2019 (UTC)[reply]

Fatality in a clinical trial should be mentioned

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053709/pdf/oncotarget-07-28059.pdf — Preceding unsigned comment added by 69.203.73.17 (talk) 03:03, 1 April 2020 (UTC)[reply]